Subthreshold Stimulation Versus Suprathreshold Stimulation in People With Chronic Low Neck Pain
Launched by BENI-SUEF UNIVERSITY · Aug 16, 2024
Trial Information
Current as of July 22, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at different types of electrical stimulation to help people with chronic neck pain. Participants will be divided into three groups: one group will receive a low level of electrical stimulation (called subthreshold), another group will receive a higher level (called suprathreshold), and the third group will receive a placebo treatment, which means they won't get the real therapy. The goal is to see which type of stimulation is most effective in relieving neck pain.
To be eligible for this study, participants need to be between 40 and 65 years old, have experienced neck pain for more than six months that is quite severe (rated as 5 or higher on a pain scale), and have specific tender points in their neck muscles. However, those currently receiving other pain treatments, such as acupuncture or pain medications, or who have certain medical conditions that could affect their safety during the trial, cannot participate. If you join the trial, you will be closely monitored throughout the study to assess how the different types of stimulation affect your neck pain.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age from 40 to 65 years old participated in this study, 2
- • Having neck pain for more than 6 months with a grade five or greater on the visual analog scale
- • Having one or more trigger points in the upper trapezius muscle,
- • A significant increase in neck muscle EMG activity indicates the presence of tender points.
- Exclusion Criteria:
- • Taking non-pharmacological therapies (e.g., acupuncture, physical therapy, osteopathy)
- • Taking oral or intravenous pain therapy, intramuscular or subcutaneous injection of cortisone, or local anesthetics during the study period,
- • Presence of any contraindication to electrical current including pregnancy, epilepsy, cardiac arrhythmia, cardiac surgery, implanted pacemaker or defibrillator, previous surgery in the spinal cord, infectious diseases of the spinal cord, malignant tumors with or without secondary blastomas in the spinal cord, severe radicular pain with acute paralysis in the extremities
About Beni Suef University
Beni-Suef University is a prominent academic institution in Egypt dedicated to advancing medical research and clinical trials aimed at improving healthcare outcomes. With a strong emphasis on innovation and collaboration, the university fosters a multidisciplinary approach to research, engaging faculty, students, and healthcare professionals in the pursuit of scientific knowledge. The institution is committed to adhering to the highest ethical standards and regulatory guidelines, ensuring that all clinical trials conducted under its auspices are designed to enhance patient care and contribute to the global body of medical research. Through its initiatives, Beni-Suef University aims to translate research findings into practical applications that benefit communities locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported